Drosophila is a powerful genetic model system for cardiovascular studies. Recently, optogenetic pacing tools have been developed to control Drosophila heart rhythm noninvasively with blue light, which has a limited penetration depth. Here we developed both a red-light sensitive opsin expressing Drosophila system and an integrated red-light stimulation and optical coherence microscopy (OCM) imaging system. We demonstrated noninvasive control of Drosophila cardiac rhythms using a single light source, including simulated tachycardia in ReaChR-expressing flies and bradycardia and cardiac arrest in halorhodopsin (NpHR)-expressing flies at multiple developmental stages. By using red excitation light, we were able to pace flies at higher efficiency and with lower power than with equivalent blue light excitation systems. The recovery dynamics after red-light stimulation of NpHR flies were observed and quantified. The combination of red-light stimulation, OCM imaging, and transgenic Drosophila systems provides a promising and easily manipulated research platform for noninvasive cardiac optogenetic studies.
Cardiac optogenetics enables noninvasive optical stimulation of the heart with high spatial and temporal precision. It has been increasingly studied as an alternative to electrical stimulation methods for cardiac control since 20101,2,3,4,5. Arrenberg et al. first developed transgenic Zebrafish models with a genetically-encoded, optically-controlled pacemaker expressing channelrhodopsin-2 (ChR2) or halorhodopsin (NpHR) in the heart2. Bruegmann et al. used ChR2-expressing cardiac tissue for light-induced stimulation of heart muscle in vitro and in mice with open chest preparation1. Over the last few years, the field of cardiac optogenetics has experienced rapid growth3,4,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30. Several groups, including ours, have been working on different frontiers in this field, and notable progress has been made. Important contributions were introduced by Nussinovitch et al., who demonstrated optogenetic pacing and resynchronization therapies in surgically exposed rat hearts in vivo4. Vogt et al. developed a gene transfer method to deliver ChR2 specifically to the adult mouse heart via a simple systemic injection of adeno-associated virus serotype 9 (AAV9)20. Cooper et al. studied the effects of neural modulation, chloride flux, temperature, and Ca2+ on the heart rate of Drosophila larva through optogenetic stimulation31,32,33. Our group developed transgenic fly models expressing ChR2 in the heart3. We demonstrated successful optogenetic pacing in fruit flies at different developmental stages, including larva, pupa, and adult flies, making it possible to study pacing effects on a developing fly heart completely non-invasively3.
About 75% of human genes associated with disease have orthologues in Drosophila. In particular, Drosophila is a powerful genetic model system for cardiovascular studies, sharing many heart similarities with vertebrates at the early developmental stages. It has a short life cycle, and is cheap and easy to manipulate34,35. Additionally, Drosophila are not dependent on their heart tubes for oxygen transport and can survive for extended periods with severe defects. This capability makes Drosophila ideal candidates for longitudinal studies of congenital heart diseases which would be fatal at early life stages for other models. We have studied Drosophila cardiac function by noninvasively monitoring the heart tube with optical coherence microscopy (OCM) in conjunction with heartrate modulation with optogenetic tools. OCM enables micron-scale 3D imaging of tissues in real time at imaging depths up to ~400 μm. The high resolution and high imaging speed allow for realtime monitoring of Drosophila heart function. The fly’s heart dimensions and heart rate can be directly measured from OCM videos to provide functional assessment of the Drosophila optogenetically controlled pacing.
In our previous work, we used blue light to pace Drosophila expressing ChR2. We were able to increase the heart rate of larva, early pupa and adult flies but were unable to reliably pace late pupa flies3. The strong absorption of blue light within the darkened cuticle of late pupa flies prevented the excitation light from penetrating to the heart tube of late pupa. A few attempts have been made to address the light penetration problem, including surgical exposure of the heart tissue4,36,37, optical fiber implantation4, increasing the light intensity38, and implanting μ-ILEDs39. However, these methods are invasive and may damage the target and surrounding tissues. As an alternative to blue light, red light (>600 nm) is a promising option for optogenetic stimulation of deep tissues since light in the red to infrared range undergoes lower scattering and absorption38,40,41. Recently, a red-shifted excitatory opsin, ReaChR, was engineered by Lin et al. to activate neurons deep within the mouse brain42. Unlike other opsins previously reported, this opsin exhibited high photocurrent efficiency at its broad spectral response peak centered on 600 nm. Inagaki et al. expressed ReaChR in the brain of Drosophila to control the complex behavior of a freely moving adult fly41. Nyns et al. used a transgenic ReaChR rat model to terminate ventricular arrhythmias in an explanted whole heart, although they did not employ red-light stimulation36. These studies suggest that incorporating ReaChR in the heart of Drosophila and performing red-light excitation can be a promising method to achieve non-invasive pacing through all the developmental stages. In this study, we seek to enhance the penetration depth of the stimulating light, extending Drosophila optogenetic pacing to all the developmental stages and improving the overall pacing efficiency.
Our previous experiment demonstrated excitatory pacing in which the Drosophila heart rate was increased. However, to model many heart conditions, it may be necessary to slow down or stop the Drosophila heartbeat. Halorhodopsin (NpHR), a widely used opsin with a red-shifted response spectrum, has been used to inhibit neuronal activities in different tissues through yellow-light stimulation2,43,44,45,46. By using red-shifted excitatory and inhibitory opsins, we can model a vast array of cardiac conditions, including tachycardia, bradycardia, and cardiac arrest. By inducing these cardiac conditions, we can study the cardiac fitness of these Drosophila models by assessing several metrics. For example, the cardiac recovery process after physical activity can be quantified by parameters such as the maximum heart rate during a physical challenge and the recovery time required to return to the resting heart rate after completing the challenge. In cardiac optogenetic pacing, the heart is forced to follow regulated frequencies, which could induce physiological cardiac distress. Investigating the heart rate recovery after optical stimulation could help to understand the impact of optical stimulation on heart function.
In this study, we demonstrated non-invasive red-light excitatory and inhibitory control of Drosophila cardiac function through cardiac optogenetics. Cardiac contractions were elicited or inhibited in two Drosophila organisms that had ReaChR or NpHR opsin transgenically expressed within the heart. The high penetration depth of red excitation light allowed us to successfully control the excitatory pace in late pupal flies. Red-light pacing had the added benefits of using a single light source for both cardiac pacing and inhibition, short excitation pulse widths, and low stimulation power densities for successful cardiac pacing. We then demonstrated restorable cardiac arrest and inhibitory pacing in NpHR Drosophila for the first time. We also introduced several metrics to characterize cardiac fitness in Drosophila, such as the recovery period, or the maximum heart rate overshoot after induced cardiac arrest. The ability to perform noninvasive pacing and imaging can advance developmental studies of congenital cardiovascular defects, especially when combined with different transgenic fly systems.
Fig. 1 provides a visual overview of this study. Fig. 1a shows the custom red LED excitation and OCM imaging system used for simultaneous optogenetic pacing and OCM imaging. The red LED (~617 nm) optically stimulates the fly heart. Compared with the maximum response wavelengths of ReaChR and NpHR (~590 nm and ~580 nm, respectively), LED light at ~617 nm can stimulate opsin-expressed tissues more efficiently due to its deeper penetration depth42. By using transgenic flies expressing ReaChR or NpHR in the heart, the light alters the conformation of the opsin and opens/closes the transmembrane region to allow ion flow and activate/inhibit heart contraction. The OCM non-invasively monitors the cardiac dynamics in vivo and in real time47. Red-light excitation requires lower amplitudes and shorter pulse widths than blue light to induce a heart contraction (Fig. 1b).
We bred transgenic flies (UAS-ReaChR; 24B-GAL4 and UAS-NpHR; 24B-GAL4) in ten ReaChR and six NpHR fruit fly lines. The heart of Drosophila is close to the dorsal side and evolves with a tubular structure during development. Using our previously developed fly line screening protocol, described in the “Methods” section and in the Supplementary Information, we found that ReaChR #53748 and NpHR #41752 were optimal fly stocks for excitatory and inhibitory pacing studies. Three pacing strategies were successfully demonstrated using the two fly stocks, as shown in Fig. 1c–e. First, to simulate tachycardia, we increased the HR in transgenic ReaChR flies by pacing the heart with a red-light pulse train at a frequency higher than the resting heart rate (RHR) of the fly (Fig. 1c). Second, to model cardiac arrest, we illuminated the heart of NpHR flies for 10 s locking open the cardiac ion channels (Fig. 1d). After demonstrating cardiac arrest, we reduced the HR in NpHR flies to model bradycardia by illuminating the heart with red-light pulses at frequencies lower than the RHR (Fig. 1e). In Fig. 1c–e, for each simulation, we plotted the heart diameter over time in the resting and pacing states, with the excitation pulse shown in the middle.
Optical simulation of tachycardia with ReaChR flies
We demonstrated red-light excitatory pacing of ReaChR Drosophila at the larval, early pupal, late pupal, and adult stages (Fig. 2a–d, Supplementary video 1–4). As illustrated in the figure, the heart was illuminated by red light pulse trains. Before optimizing the pacing pulse, a pulse width of 40 ms and excitation power density of 7.26 mW mm−2 were used for pacing at each developmental stage. By analyzing 2D M-mode images acquired in 31 s through OCM imaging, we determined that the RHRs of the larval, early pupal, late pupal, and adult stages of the example fly were 4.4 Hz, 2.4 Hz, 2.5 Hz, and 5.7 Hz, respectively. Then, for example, specimens of the same fly type as in Fig. 2, we applied optical pacing at three frequencies above the initially measured RHR for all four stages: 5.5, 6.0, 6.5 Hz for the larval stage; 3.5, 4.0, 4.5 Hz for the early pupal stage; 4.5, 5, 5.5 Hz for the late pupal; and 9.0, 9.5, and 10 Hz for the adult stage. As shown in Fig. 2a–d, the pacing rates (PRs) and measured heart rates (HRs) during pacing are indicated with red and black fonts in the M-mode images. The result demonstrated that each light pulse successfully elicited a heart contraction. The HRs followed the PRs, and reverted to the original individual RHRs after pacing was finished. The hearts of wild type (WT) control flies were not affected by the pacing light pulses at any developmental stage (Fig. 2a–d).
After demonstrating red-light excitatory pacing, we optimized the pacing parameters, including the excitation power density and pulse width at the larval, early pupal, late pupal, and adult stages, as shown in Fig. 3a–d. Figure 3a shows the pacing results for a late pupa, which are demonstrated for the first time. We varied the LED excitation power densities from 0.46 mW mm−2 to 7.26 mW mm−2 (top to bottom in Fig. 3a) with a pulse width of 10 ms, and found that each pulse was able to elicit one heart contraction when the excitation power density was greater than 1.86 mW mm−2. The HR diverged from the PR (5 Hz) at lower power densities. Statistical analysis of the power amplitude was performed by pacing multiple fruit flies at each stage (Fig. 3b). The optimal red-light excitation power density of 3.63 mW∙mm−2 enabled a hundred percent pacing probability at all the stages. In comparison, blue-light pacing required inputs of 35.5 mW mm−2 for ChR2 larval and early pupal stages, and 12 mW mm−2 for adults3. The red-light optical exposure was well below the maximum permissible exposure (MPE) recommended by ANSI for safe use of lasers on skin (ANSI Z136.1) (7.26 mW mm−2 vs. 27.41 mW mm−2).
With the optimized power density, we further characterized the optimal excitation pulse width. The M-mode images in Fig. 3c illustrate the HRs of a late pupa paced with pulse widths of 2 ms, 5 ms, 10 ms, 20 ms, and 40 ms (top to bottom). Pulse widths wider than 5 ms led to robust optical pacing. The influence of the pulse width on the pacing probability was then quantified for each developmental stage (larva, early pupa, late pupa, and adult) (Fig. 3d). At each stage, a hundred percent pacing probability could be achieved with a pulse width of 40 ms. The minimum pulse widths for this achievement were demonstrated to be 20 ms for the larval and early pupal stages, and 10 ms for the late pupal and adult stages. As expected, shorter pulse widths resulted in lower success rates at each stage. No flies could be paced when the pulse width was decreased to 2 ms.
With the optimal power density and pulse width, the paceable frequency range over which pacing could be achieved was studied for individual developmental stages (Fig. 3e, f, g, h). The HR was tuned around the average RHR of the respective stages. In larvae, the fly heart linearly followed the pacing frequency from 3.5 to 7 Hz, where the average RHR was 3.5 Hz. In early pupae, the average RHR was 2.1 Hz, and the heart linearly followed the pacing frequency in the range between 2 and 4 Hz. For late pupae, the average RHR was 2.8 Hz, and the heart linearly followed the pacing frequency in the range between 2.5 and 4.5 Hz. During the adult stage (with a higher average RHR of 7 Hz), the HR and pacing frequency showed a linear relationship between 6.5 and 11 Hz. The maximum paceable heart rates (maxPR) were observed to be ~167%, ~218%, ~219%, and ~143% of the RHR for the larval to adult stages, demonstrating a broad controllable HR range throughout the life cycle of Drosophila. Pacing frequencies too far from the RHR caused the HR to deviate from the PR, which is consistent with previous conclusions obtained using ChR22,3.
Optically modeling cardiac arrest and bradycardia with NpHR flies
Restorable cardiac arrest
With NpHR flies, we demonstrated restorable cardiac arrest at different developmental stages (Supplementary video 5–7). The inhibitory microbial opsin NpHR was expressed in the heart of Drosophila along with YFP through the transgenesis technique (Fig. 4a). As shown in Fig. 4b, the M-mode images indicate the influence of continuous red-light illumination on the heart functions. The heartbeats of the larval, early pupal, and late pupal flies instantly stopped when illuminated with red light. Cardiac arrest was sustained during continuous illumination of the heart for 10 s. After switching off the red light, the heartbeat immediately restarted. A control experiment was performed using WT flies for each stage. The heart function was unaffected by red light stimulation in control flies.
We characterized the red-light excitation power density to study the probability of inducing cardiac arrest at different stages (Fig. 4c). The power density was tuned up from 0.12 mW mm−2 to 7.26 mW mm−2, and applied to larval, early pupal, and late pupal flies. Multiple flies were measured for each stage as seen in Supplementary Table 3. For each stage, 3.63 mW mm−2, 0.46 mW mm−2, and 7.26 mW mm−2 were the lowest powers capable of efficient cardiac inhibition. Lower power levels led to reduced cardiac arrest probabilities. In particular, early pupal flies required relatively low power (e.g., 0.46 mW mm−2) for reliable cardiac arrest.
With the ability to suppress cardiac contractions in NpHR flies, it is possible to simulate the regularly seen cardiac arrhythmia, bradycardia (Supplementary video 8–10). Here, we optimized optogenetic inhibitory pacing by simultaneously tuning the frequency of the excitation-light pulse train and the pulse duty cycle for each NpHR fly.
For a specific frequency, the duty cycle was tuned to allow one heart contraction between two adjacent pulses. As shown in Fig. 4d, we controlled the HRs of the example NpHR larva, early pupa, and late pupa by adjusting the duty cycle for individual red-light pulse trains at frequencies of 2 Hz, 1 Hz, and 0.6 Hz, all at a power density 7.12 mW mm−2. For the larva, duty cycles of 80%, 90%, and 90% were used for the respective frequencies. The time between adjacent pulses in each pulse train, 100 ms, 100 ms, and 167 ms, allowed for one heart contraction by the larva at each frequency. For the early pupa, inter-pulse times of 175 ms, 200 ms, and 333 ms were used to allow for a single heartbeat, and 200 ms, 300 ms, and 333 ms were used for the late pupa. The heart rates were successfully slowed to various lower frequencies, and restored to the RHR after the optical stimulation was suspended. Even with different RHRs, the larva, early pupae, and late pupae could be paced at identical frequencies.
Heart rate recovery after cardiac arrest
During simulation of cardiac arrest using NpHR flies, we observed heart rate recovery process after red-light stimulating the fly heart. We investigated the recovery dynamics using NpHR early pupal flies by inducing cardiac arrest for different time periods. Specifically, the heart of an NpHR early pupa was monitored for 60 s, with cardiac arrest induced after imaging the heart for 5 s in the resting state. To induce different cardiac arrest periods, red-light LED illumination was continuously applied for periods of 1 s, 2 s, 5 s, 10 s, and 20 s, respectively for each fly. Heart rate recovery after the illumination was studied by analyzing the maximum heart rate (maxHR) and the recovery time. The heart rate was normalized by the mean RHR of the first 5 s of the OCM recording to adjust for the heart rate differences between individual flies. We regard a normalized heart rate within 80%-120% as a restored RHR after cardiac arrest. Fig. 5a shows the dynamic heart rate recovery process of an NpHR early pupa after cardiac arrest challenges of 1 s, 2 s, 5 s, 10 s, and 20 s, respectively. With 1 and 2 s cardiac arrest, the fly heart rate returned to its RHR immediately after red-light inhibition. With the longer inhibition time, an overshoot of HR and an increased recovery time were observed following the cardiac arrests. With a 20 s inhibition, an ~150% HR overshoot and ~25.4 s recovery time were observed from this fly. To further evaluate the consistency of this phenomenon, we induced cardiac arrest in 18 flies for different stimulation durations and imaged the fly heart beat for 60 s to analyze the heart rate recovery. In Fig. 5b, we plotted the mean and standard deviation of the heart rate at each time point. Consistent with what is shown in Fig. 5a, the fly HR returned to the RHR immediately after 1 or 2 s of cardiac arrest stimulation. For longer stimulations, the mean HR overshoot and recovery time were found to be 130% and 4.62 s, 141% and 8.17 s, and 177% and 10.85 s for cardiac arrest times of 5 s, 10 s, and 20 s, respectively. To look into the relationship of the cardiac recovery process with arrest time, we compared the means and medians of the HR overshoots and recovery times for the five cardiac arrest periods. As shown in Fig. 5c, d, the overshoot and recovery time started to show statistically significant differences when the arrest time increased to 5 s.
Compared to the blue light conventionally used for optogenetic pacing, light in the red to infrared range undergoes low scattering and absorption41. Multiple red-shifted opsins have been engineered in the past several years to excite or inhibit neural or cardiomyocyte activities42,48,49,50,51. Some red-shifted opsins have been applied in optogenetic control of deep tissue, such as controlling neuronal activities in the mouse cortex through an intact skull42, and behavioral control of freely moving flies41,52. Here, we leverage the features of red-shifted opsins to demonstrate non-invasive cardiac control through red-light stimulation.
Among the available red-shifted excitatory opsins, ReaChR is popular with optogeneticists for applications requiring deep penetration36,41,52. In this study, we applied ReaChR to the cardiac Drosophila model. We successfully showed that red-light stimulation can induce depolarization in ReaChR-expressing Drosophila hearts, causing heart contractions. Previously, late pupae expressing ChR2 were not able to be paced due to their highly pigmented cuticle3, but red light has been confirmed to have deeper optical penetration through the cuticle of Drosophila than blue light41. Here, in addition to pacing larva, early pupae, and adult flies, the late pupae were also able to be paced successfully. With the addition of late pupae, optogenetic tachypacing can be successfully carried out throughout the Drosophila life cycle.
Tachypacing ReaChR-expressing flies was further explored by looking into the excitation power density, pulse width, and extensible heart rate. Pacing probabilities decreased with reduced excitation power densities, which was expected since lower power leads to decreased photocurrent passing through myocardial cell membranes and is less likely to open ReaChR-constructed ion channels. The minimum power density for robust pacing with red light was demonstrated to be 3.63 mW mm−2, which is considerably lower than the required blue light energies of 35.5 mW mm−2 for larvae and early pupae, and 12 mW mm−2 for adults3. The increased efficiency may be accounted for by the enhanced penetration depth of red light. ReaChR flies also required shorter illumination pulse widths for successful excitation than ChR2-expressing flies. Here, 20 ms was demonstrated as the optimal pulse width for pacing larval and early pupal flies, while only 10 ms was required for pacing late pupal and adult ReaChR flies. Adult ReaChR flies were paced more efficiently than ChR2 adults, which required 20 ms for reliable pacing. Furthermore, 100% of ReaChR adult flies were able to be paced, indicating high pacing reliability3. The short optimal pulse widths required for excitatory pacing may be caused by the fast kinetics of ReaChR-constructed cation channels3,42. Fast opsin kinetics indicate rapid opening of the light-gated channels under illumination, which allows sufficient cations to cross the cell membrane and elicit action potentials in cardiomyocytes42,53.
To model pathologies such as ventricular arrhythmia or bradycardia, we developed Drosophila models expressing the inhibitory opsin NpHR within the myocardium36,37. We took advantage of the same red LED source used for pacing ReaChR flies. Here, we are able to use NpHR-expressing Drosophila to reliably mimic both cardiac arrest and bradypacing in the larval, early pupal, and late pupal stages. To our knowledge, this is the first demonstration of restorable cardiac arrest and precise control of heartrates less than the RHR in intact Drosophila at multiple developmental stages. In the adult stage, cardiac function inhibition was observed only occasionally and for only 1–2 s in some flies (Supplementary Fig. 1). This phenomenon might be due to a more active metabolism or a more extensively innervated adult cardiac muscle layer. High inhibition probabilities were demonstrated at low excitation power densities in the larval, early pupal, and late pupal stages. The optimal power densities were demonstrated to be 3.63 mW mm−2, 0.46 mW mm−2, and 7.26 mW mm−2, respectively for each stage, all of which are less than the ANSI standard for skin exposure, indicating safe LED red-light stimulations.
Our research platform not only enables simulation of various cardiac pathologies, but also enables investigation of cardiac physiology after a short challenge. For humans, the heart rate and recovery time after exercise are good indicators of fitness. Health problems lead to higher heart rates and prolonged recovery periods after exercise. In previously exercised Drosophila, the recovery from cardiac arrest induced by electrical pacing was shown to be faster than the recovery period for Drosophila that had not been exercised54. Here the arrest recovery dynamics were initiated through optogenetic stimulation of NpHR Drosophila. The heart rate rapidly overshot the RHR after optical stimulation, and then exhibited exponential decay until returning to the resting heartrate. This recovery paradigm is similar to heartrate recovery after physical exercise in humans. The maximum heart rate and recovery time were shown to increase with arrest duration, suggesting optogenetic-stimulation induced indicators of cardiac health common to both vertebrate and non-vertebrate models.
While cardiac pacing’s most famous and beneficial application, implanted electrical pacemakers in humans, is clinical, cardiac pacing can also be used as a powerful research tool. Electrical pacing in Drosophila has been used extensively to quantify aging-induced cardiac dysfunction and arrhythmias55,56,57. Studies have induced cardiac decline in Drosophila with electrical tachypacing and have correlated the organisms’ susceptibility to this decline with aging, and as well as associating it with human ortholog disease genes58,59,60. To tachypace the Drosophila in these studies, electrical current was applied across the entire fly, which causes inhomogeneous and non-specific stimulation and may cause thermal damage or other detrimental effects to the animal. Here, we not only demonstrate tachycardia effectively and non-invasively in Drosophila, but also are able to conduct real-time imaging for heart function monitoring. With the non-invasive platform, each adult can be longitudinally tracked during the aging process, without requiring that each fly be sacrificed after each pacing performance, which is promising for aging-related heart function studies.
More extensive research could be performed based on this study. First of all, opportunities could be explored in cardiac pathology studies. In vertebrate models, including rats, rabbits, and dogs, cardiac pacing has been used to simulate tachycardia, bradycardia, and cardiac failure, and to study molecular and epigenetic effects of these cardiac modes. With tachycardia animal models, dynamics such as conduction velocity and gap junction properties61, hemodynamic deterioration62, and intracellular Ca2 + dynamics63 have been analyzed. Potassium channel subunit regulation64, and the relation between endogenous physiological late Na+ current and bradycardia-related ventricular arrhythmias65 were investigated by simulating bradycardia. ReaChR and NpHR could be expressed in these vertebrate models to study these long-term epigenetic changes with reduced invasiveness over electrical pacing, although, with vertebrates, surgery would still be required to implant illumination devices. Second, the developed red-shifted fly models could be complementary to vertebrate models for physiological or pathological studies via red light cardiac control. They could also be further transgenically manipulated to study human-ortholog-gene mutant induced pathologies. Furthermore, the platform could be applied in developmental biology studies. For example, the capabilities of increasing and reducing the heart rate as well as stopping the heartbeat of Drosophila are powerful for investigating the interplay between molecular and mechanical stimuli in normal heart development, as well as pathologies such as tachycardia, bradycardia, and cardiac arrest. By creating cardiac arrhythmia non-invasively, mutants of the molecular candidates of Ca2+ or potassium ion channels that cause cardiac conduction disorders, such as cardiac hypertrophy or cardiac arrhythmias, could be further understood.
The OCM integrated platform also provides opportunities in both hardware and software for animal cardiac studies. The non-invasive nature of the OCM technique enables longitudinal monitoring of cardiac function during optical control without damaging the cardiac tissue. As a label-free technique, it could become a promising complement to previous Drosophila cardiac assessment methods that require staining, such as optical mapping, immunofluorescence, or histology5,37. The use of red excitation light for optogenetic cardiac control enables higher penetration depth and longitudinal cardiac arrhythmia studies. The combination of OCM and optogenetics establishes an all-optical, non-invasive manipulation and real-time imaging modality for cardiac optogenetics.
Even though our system is promising for cardiac studies, there are several limitations. First, the LED light source used for red-light excitation is difficult to focus specifically on the pacemaker region in Drosophila, which increases the total power necessary for excitation. This concern could be addressed by using a red laser source instead of an LED. Second, even though efficient non-invasive cardiac control was realized in Drosophila using red LED light, the penetration depth is insufficient for controlling the heart functions of intact large animals. The OCM system is also not suitable for large animal heart imaging in vivo.
In conclusion, we developed ReaChR and NpHR Drosophila models and an integrated non-invasive red-light cardiac control and OCM imaging system. We successfully mimicked restorable tachycardia, bradycardia, and cardiac arrest at different developmental stages, and demonstrated improved pacing efficiencies using red LED light (617 nm) stimulation. The Drosophila heartbeat can be precisely manipulated in real time by modifying the frequency and pulse width of the red light. The recovery dynamics after red light stimulation of NpHR flies were observed and quantified. The red-light stimulation, OCM imaging, and transgenic Drosophila systems provide promising research platforms for cardiac optogenetic studies in the future.
Transgenic fly model and fly culture
24B-GAL4 was used as the driver of UAS-mediated opsin expression3 in the heart of Drosophila melanogaster. By crossing UAS-ReaChR or UAS-NpHR-YFP flies with 24B-GAL4 flies, targeted expressions of ReaChR (UAS-ReaChR; 24B-GAL4) and NpHR (UAS-NpHR; 24B-GAL4) were achieved in cardiac tissue. Wild type (WT) W118 flies were crossed with 24B-GAL4 flies to obtain 24B-GAL4/+ as the control. Details about fly model development and selection are provided in Supplementary Notes and Supplementary Tables 1 and 2.
We prepared fly food by mixing Formula 4–24 (Instant Drosophila Medium; Carolina Biological Supply Company), water, and 10 mM all-trans-retinal (ATR) (Toronto Research Chemicals Inc.) solution, which used 200 proof ethanol as the solvent. The ATR concentrations in food used for culturing ReaChR and NpHR flies were 3 mM and 10 mM, respectively, in order to achieve sufficient opsin expressions in the heart. Developed flies were transferred into a vial with the prepared formula and kept in an incubator at 25 °C for ~10 h for cross breeding. Flies in the first generation were obtained at the larval, early pupal, late pupal, and adult stages for cardiac control and optical imaging experiments. Normal food was prepared by mixing formula 4–24 and water for culturing WT flies at the same temperature.
Integrated red-light excitation and OCM imaging system
We developed an integrated red LED excitation and OCM imaging system for simultaneous, non-invasive cardiac stimulation and monitoring in Drosophila (Fig. 1a). The OCM system used a portion of a supercontinuum laser source to provide near-infrared light with a central wavelength of 800 nm and a bandwidth of 220 nm3. The axial and transverse resolutions of ~1.5 μm and ~3.6 μm in tissue were obtained by using the broadband source and a ×10 objective lens respectively to resolve the fly heart structure. A 2048 pixel line scan camera was utilized to detect the interference signal of the back-reflected light from the two arms of the OCM system.
To perform optogenetic control of heart functioning, we integrated a 617 nm LED light source (Migtex Systems, BLS-LCS-0617-03-22) into the OCM sample arm through a dichroic mirror and focused the light to the same point of the imaging beam through the objective lens with a spot size of ~2.2 mm, covering the entire heart tube. Control software provided by Migtex Systems allowed tuning of the light intensity. A Labview program was used to control the pulse width (or duty cycle) and frequency of the LED signal, and to synchronize the M-mode image acquisition for the OCM system through a function generator (Agilent 33210 A, Keysight technologies, USA) and a DAQ card (National Instrument USB-6008).
Optical excitation and OCM imaging protocol
The focused excitation light illuminated the entire heart tube in both ReaChR and NpHR flies at each developmental stage. For excitatory optical pacing, power densities of 7.26 mW mm−2 and 3.63 mW mm−2, and pulse widths of 20 ms and 10 ms were used for larva and early pupa screenings, and late pupa and adult fly screenings, respectively, to identify the flies which could be paced. Flies that could be successfully paced at frequencies 20% higher than their RHRs were selected for experiments. Three pacing pulse trains were applied serially during each OCM measurement, with each pulse train lasting for ~4.5 s. Then, 4096 cross-sectional images were acquired in ~32 s at the frame rate of ~130 frames/s from the posterior segments of the larval and early pupal heart, and the anterior portions of the late pupal and adult heart. M-mode images were acquired from the cross-sectional images, using ImageJ to analyze the time-lapsed heart function with and without red-light stimulations. Control flies were paced and imaged with identical procedures. For all the identified ReaChR flies, we modulated the excitation power densities from 0.46 mW mm−2 to 7.26 mW mm−2, the pulse widths from 2 ms to 40 ms, and pulse frequencies from 0.5 Hz above the RHRs to higher values until divergence of HR from PR was observed.
Cardiac arrest and inhibitory pacing protocol
To demonstrate restorable cardiac arrest, 10 s of continuous red light was used to identify viable larva, early pupa, late pupa, and adult flies, with an excitation power density of 7.26 mW mm−2. After discerning viable flies, power intensities were tuned from 0.12 mW mm−2 to 7.26 mW mm−2 to characterize the effect of stimulation power on the cardiac arrest rate for each developmental stage. For inhibitory pacing, duty cycles of excitation pulse trains were modified for individual flies. Pulse frequencies of 2 Hz, 1 Hz, and 0.6 Hz were tested at the excitation power density of 7.26 mW mm−2. The single heart contractions between adjacent pulses indicated the heart rate at the respective frequencies.
Protocol for study of heart rate recovery
To investigate the heartbeat recovery after cardiac arrest in NpHR flies, we monitored the heart of each early pupa for 60 s through the OCM imaging technique. Before demonstrating cardiac arrest, the minimum excitation power was determined for individual flies by observing the heartbeat during red light excitation. After allowing the heart to beat for 5 s at the RHR, different cardiac arrests were then generated by stimulating the heart for 1 s, 2 s, 5 s, 10 s, or 20 s. To compare the cardiac-arrest-induced cardiac recovery dynamics between different arrest periods, two-sided Student’s t-tests were used for statistical analysis and results were considered statistically significant at p < 0.05.
Statistical analyses and reproducibility
Experiments were repeated independently on multiple flies as mentioned in the text and figure legends. Data were characterized using two-sided Student’s t-tests and represented as mean ± SD.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
M-mode images were generated using a free software, ImageJ. Standard statistical analysis (Student’s t-test) was performed using standard functions included in Matlab. No custom code deemed central to the conclusions is used.
Bruegmann, T. et al. Optogenetic control of heart muscle in vitro and in vivo. Nat. methods 7, 897–900 (2010).
Arrenberg, A. B., Stainier, D. Y., Baier, H. & Huisken, J. Optogenetic control of cardiac function. Science 330, 971–974 (2010).
Alex, A., Li, A., Tanzi, R. E. & Zhou, C. Optogenetic pacing in Drosophila melanogaster. Sci. Adv. 1, e1500639 (2015).
Nussinovitch, U. & Gepstein, L. Optogenetics for in vivo cardiac pacing and resynchronization therapies. Nat. Biotechnol. 33, 750–754 (2015).
Entcheva, E. & Bub, G. All-optical control of cardiac excitation: combined high-resolution optogenetic actuation and optical mapping. J. Physiol. 594, 2503–2510 (2016).
Abilez, O. J. et al. Multiscale computational models for optogenetic control of cardiac function. Biophys. J. 101, 1326–1334 (2011).
Jia, Z. H. et al. Stimulating cardiac muscle by light cardiac optogenetics by cell delivery. Circ. Arrhythm. Electrophysiol. 4, 753–760 (2011).
Sasse, P. Optical Pacing of the Heart The Long Way to Enlightenment. Circ. Arrhythm. Electrophysiol. 4, 598–600 (2011).
Boyle, P. M., Williams, J. C., Ambrosi, C. M., Entcheva, E. & Trayanova, N. A. A comprehensive multiscale framework for simulating optogenetics in the heart. Nat. Commun. 4, 2370 (2013).
Williams, J. C. et al. Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model. PLos Comput. Biol. 9, e1003220 (2013).
Yu, J. Z., Boyle, P. M., Ambrosi, C. M., Trayanova, N. A. & Entcheva, E. High-throughput contactless optogenetic assay for cellular coupling: illustration by Chr2-light-sensitized cardiac fibroblasts and cardiomyocytes. Circulation 128, 14949 (2013).
Ambrosi, C. M., Klimas, A., Yu, J. Z. & Entcheva, E. Cardiac applications of optogenetics. Prog. Biophys. Mol. Biol. 115, 294–304 (2014).
Beiert, T., Bruegmann, T. & Sasse, P. Optogenetic activation of G(q) signalling modulates pacemaker activity of cardiomyocytes. Cardiovasc. Res. 102, 507–516 (2014).
Bingen, B. O. et al. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. Cardiovasc. Res. 104, 194–205 (2014).
Makowka, P., Bruegmann, T., Beiert, T., Hesse, M. & Sasse, P. Precise spatio-temporal modulation of cardiac pacemaker activity by optogenetic GS stimulation. Acta Physiol. 210, 156–156 (2014).
Nussinovitch, U., Shinnawi, R. & Gepstein, L. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. Cardiovasc. Res. 102, 176–187 (2014).
Park, S. A., Lee, S. R., Tung, L. & Yue, D. T. Optical mapping of optogenetically shaped cardiac action potentials. Sci. Rep. 4, 6125 (2014).
Bruegmann, T. & Sasse, P. Optogenetic cardiac pacemakers: science or fiction? Trends Cardiovasc. Med. 25, 82–83 (2015).
Chan, V. et al. Fabrication and characterization of optogenetic, multi-strip cardiac muscles. Lab Chip 15, 2258–2268 (2015).
Vogt, C. C. et al. Systemic gene transfer enables optogenetic pacing of mouse hearts. Cardiovasc. Res. 106, 338–343 (2015).
Wengrowski, A. M. et al. Optogenetic release of norepinephrine from cardiac sympathetic neuronsalters mechanical and electrical function. Cardiovasc. Res. 105, 143–150 (2015).
Williams, J. C. & Entcheva, E. Optogenetic versus electrical stimulation of human cardiomyocytes: modeling insights. Biophys. J. 108, 1934–1945 (2015).
Jia, Z. et al. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ. Arrhythm. Electrophysiol. 4, 753–760 (2011).
Entcheva, E. Cardiac optogenetics. Am. J. Physiol. Heart Circ. Physiol. 304, H1179–H1191 (2013).
Entcheva, E. Fiat lux in understanding cardiac pacing, resynchronization and signalling by way of optogenetics. Cardiovasc. Res. 102, 342–343 (2014).
Koopman, C. D., Zimmermann, W. H., Knöpfel, T. & de Boer, T. P. Cardiac optogenetics: using light to monitor cardiac physiology. Basic Res. Cardiol. 112, 56 (2017).
Boyle, P. M., Karathanos, T. V. & Trayanova, N. A. Cardiac optogenetics: 2018. JACC Clin. Electrophysiol 4, 155–167 (2018).
Shaheen, N., Gruber, A. & Gepstein, L. Light and the heart: cardiac optogenetics. 152, https://onlinelibrary.wiley.com/doi/abs/10.1002/9781119152637.ch13 (2019).
Gruber, A., Edri, O. & Gepstein, L. Cardiac optogenetics: the next frontier. Europace 20, 1910-1918 (2018).
Diaz-Maue, L., Luther, S. & Richter, C. in Optogenetics and Optical Manipulation 2018. 104820G (International Society for Optics and Photonics).
Stanley, C. E., Mauss, A. S., Borst, A. & Cooper, R. L. The effects of chloride flux on Drosophila heart rate. Methods Protoc. 2, 73 (2019).
Zhu, Y. C., Uradu, H., Majeed, Z. R. & Cooper, R. L. Optogenetic stimulation of Drosophila heart rate at different temperatures and Ca2+ concentrations. Physiol. Rep. 4, e12695 (2016).
Malloy, C. et al. Using optogenetics to assess neuroendocrine modulation of heart rate in Drosophila melanogaster larvae. J. Comp. Physiol. A 203, 791–806 (2017).
Li, A. et al. Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment. Hum. Mol. Genet. 26, 1472–1482 (2017).
Alex, A. et al. A circadian clock gene, Cry, affects heart morphogenesis and function in Drosophila as revealed by optical coherence microscopy. PloS one 10, e0137236 (2015).
Nyns, E. C. et al. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management. Eur. Heart J. 38, 2132–2136 (2016).
Bruegmann, T. et al. Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. J. Clin. Investig. 126, 3894–3904 (2016).
Ambrosi, C. M. & Entcheva, E. Optogenetics ‘promise: pacing and cardioversion by light? Future Cardiol. 10, 1–4 (2014).
Kim, R.-H. et al. Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat. Mater. 9, 929 (2010).
Boyle, P. M., Karathanos, T. V. & Trayanova, N. A. “Beauty is a light in the heart”: the transformative potential of optogenetics for clinical applications in cardiovascular medicine1. Trends Cardiovasc. Med. 25, 73–81 (2015).
Inagaki, H. K. et al. Optogenetic control of freely behaving adult Drosophila using a red-shifted channelrhodopsin. Nat. Methods 11, 325 (2014).
Lin, J. Y., Knutsen, P. M., Muller, A., Kleinfeld, D. & Tsien, R. Y. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat. Neurosci. 16, 1499–1508 (2013).
Gradinaru, V., Mogri, M., Thompson, K. R., Henderson, J. M. & Deisseroth, K. Optical deconstruction of parkinsonian neural circuitry. Science 324, 354–359 (2009).
Busskamp, V. et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. science 329, 413–417 (2010).
Song, J., Ampatzis, K., Björnfors, E. R. & El Manira, A. Motor neurons control locomotor circuit function retrogradely via gap junctions. Nature 529, 399 (2016).
Chang, C. Y. et al. Brief optogenetic inhibition of dopamine neurons mimics endogenous negative reward prediction errors. Nat. Neurosci. 19, 111 (2016).
Men, J. et al. Drosophila preparation and longitudinal imaging of heart function in vivo using optical coherence microscopy (OCM). J. Vis. Exp. e55002–e55002 (2016).
Klapoetke, N. C. et al. Independent optical excitation of distinct neural populations. Nat. Methods 11, 338–346 (2014).
Chuong, A. S. et al. Noninvasive optical inhibition with a red-shifted microbial rhodopsin. Nat. Neurosci. 17, 1123–1129 (2014).
Govorunova, E. G., Spudich, E. N., Lane, C. E., Sineshchekov, O. A. & Spudich, J. L. New channelrhodopsin with a red-shifted spectrum and rapid kinetics from Mesostigma viride. MBio 2, e00115–00111 (2011).
Zhang, F. et al. Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri. Nat. Neurosci. 11, 631–633 (2008).
Inagaki, H. K. et al. Optogenetic control of Drosophila using a red-shifted channelrhodopsin reveals experience-dependent influences on courtship. Nat. Methods 11, 325–332 (2014).
Mattis, J. et al. Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat. Methods 9, 159 (2012).
Piazza, N., Gosangi, B., Devilla, S., Arking, R. & Wessells, R. J. P. o. Exercise-training in young Drosophila melanogaster reduces age-related decline in mobility and cardiac performance. PLoS ONE 4, e5886 (2009).
Nishimura, M., Ocorr, K., Bodmer, R. & Cartry, J. Drosophila as a model to study cardiac aging. Exp. Gerontol. 46, 326–330 (2011).
Ocorr, K., Vogler, G. & Bodmer, R. Methods to assess Drosophila heart development, function and aging. Methods 68, 265–272 (2014).
Paternostro, G. et al. Age-associated cardiac dysfunction in Drosophila melanogaster. Circ. Res. 88, 1053-1058 (2001).
Ocorr, K. et al. KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging. Proc. Natl Acad. Sci. USA 104, 3943–3948 (2007).
Wessells, R. et al. d4eBP acts downstream of both dTOR and dFoxo to modulate cardiac functional aging in Drosophila. Aging Cell 8, 542–552 (2009).
Wessells, R. J., Fitzgerald, E., Cypser, J. R., Tatar, M. & Bodmer, R. Insulin regulation of heart function in aging fruit flies. Nat. Genet. 36, 1275 (2004).
Akar, F. G. et al. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am. J. Physiol.Heart Circ. Physiol. 293, H1223–H1230 (2007).
Karpawich, P. P., Justice, C. D., Cavitt, D. L. & Chang, C.-H. Developmental sequelae of fixed-rate ventricular pacing in the immature canine heart: an electrophysiologic, hemodynamic, and histopathologic evaluation. Am. Heart J. 119, 1077–1083 (1990).
Chudin, E., Goldhaber, J., Garfinkel, A., Weiss, J. & Kogan, B. Intracellular Ca2+ dynamics and the stability of ventricular tachycardia. Biophys. J. 77, 2930–2941 (1999).
Tsuji, Y., Zicha, S., Qi, X.-Y., Kodama, I. & Nattel, S. Potassium channel subunit remodeling in rabbits exposed to long-term bradycardia or tachycardia: discrete arrhythmogenic consequences related to differential delayed-rectifier changes. Circulation 113, 345–355 (2006).
Wu, L. et al. Late sodium current contributes to the reverse rate-dependent effect of ikr inhibition on ventricular repolarizationclinical perspective. Circulation 123, 1713–1720 (2011).
We would like to acknowledge our funding support by the National Science Foundation [NSF1455613 to C.Z. and A.L., the National Institute of Health (R15EB019704 to C.Z. and A.L., R01EB025209 to C.Z., R03AR063271 to A. L and R01AG014713 and R01MH60009 to R.E.T.), and Cure Alzheimer’s Fund [to R.E.T.]. We would also like to acknowledge J. Ballard, G. Ni, Q. Guo, S. Wang, J. Yu, F. Cai, Z. Li, and Y. Huang for suggestions of figure preparation and helpful discussions.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Men, J., Li, A., Jerwick, J. et al. Non-invasive red-light optogenetic control of Drosophila cardiac function. Commun Biol 3, 336 (2020). https://doi.org/10.1038/s42003-020-1065-3
This article is cited by
Scientific Reports (2020)